Determining Whether Agonist Density or Agonist Number Is More Important for Immune Activation via Micoparticle Based Assay
P. Deak, F. Kimani, B. Cassaidy, & A. Esser-Kahn. Front Immunol 11: 642.
Peter Deak, Ph.D.
-
NIAID ImEPosT T32 Fellow
- Websites: View full profile
- Contact: pdeak@uchicago.edu
-
Office Location:
Kovler Viral Oncology Laboratory, 910 E 58th St, Chicago, IL 60637